Pure Global
NCT06208397

MRE for Assessment of Histopathological Growth Patterns in Colorectal Liver Metastases

Noninvasive Evaluation in Diagnosis and Treatment of Histopathological Growth Patterns in Colorectal Liver Metastases Using MR Elastography-based Shear Strain Mapping
Shengjing Hospital·ClinicalTrials.gov·diagnostic testRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Metastatic Colorectal Cancer
Drug/Device/Intervention
Magnetic Resonance Elastography and routine MRI
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Shengjing Hospital
Location
Shenyang, China
Timeline & enrollment
Phase
N/A
Start date
Dec 24, 2023
End date
Dec 24, 2025
Enrollment
50 participants
Primary outcome

Radiological assessment of CRLM

Summary

The goal of this study is to investigate the value of MR elastography-based SII as a means of
 detecting HGP noninvasively in patients with pathology-proven CRLM. MRE will provide a direct
 measure of tumor-liver adhesion to investigate the relationship between imaging findings and
 pathophysiological changes in the Liver.

ICD-10 classifications
Malignant neoplasm of colonMalignant neoplasm: Colon, unspecifiedMalignant neoplasm: Descending colonMalignant neoplasm: Ascending colonMalignant neoplasm: Overlapping lesion of colon
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06208397
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06208397 through Pure Global AI's free database. This phase not specified trial is sponsored by Shengjing Hospital and is currently Recruiting. The study focuses on Metastatic Colorectal Cancer. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.